Sun Pharmaceutical Industries Limited has received requests from three members of the Promoter Group seeking a formal reclassification of their status to the Public category. The individuals involved include Mr. Sudhir Vrundavandas Valia, Mrs. Raksha Sudhir Valia, and Mrs. Krishna Vrundavandas Valia. Collectively, these individuals hold 4,31,75,371 shares, representing 1.80% of the company’s total equity. The request is currently pending review by the company’s board.
Details of the Reclassification Request
On May 14, 2026, Sun Pharmaceutical Industries Limited formally acknowledged requests from key members of the promoter group seeking to transition their classification to the public category. This move marks a significant shift in the company’s shareholding structure regarding its promoter group status.
Shareholding Impact
The individuals transitioning are significant shareholders in the company. Specifically, Mr. Sudhir Vrundavandas Valia holds 1,43,45,019 shares (0.60%), while Mrs. Raksha Sudhir Valia holds 2,88,30,352 shares (1.20%). Mrs. Krishna Vrundavandas Valia is also part of the reclassification request. Together, these holdings account for 4,31,75,371 shares, or 1.80% of the total shares held.
Next Steps for Approval
The company has initiated an internal examination process for these requests, which will be aligned with standard corporate governance protocols. These proposals will be presented to the Board of Directors for their formal consideration. Following board approval, the company will proceed with the necessary administrative steps and official filings to finalize the reclassification process.
Source: BSE
